The upregulation of MYC targets and the alteration of RNA metabolism point toward a critical role of SF3B1 in regulating alternative RNA splicing and subsequently impacting vital cellular processes to regulate the aggressiveness of CLL. Here, MYC is linked to B-cell chronic lymphocytic leukemia.